Remodeling tumor microenvironment with nanomedicines.

Area of Science:

• Oncology
• Nanomedicine
• Cancer Biology

Background:

• The tumor microenvironment (TME) significantly impacts cancer malignancy and resistance to therapies.
• Re-engineering the TME is a key strategy to improve antitumor treatment efficacy.
• Nanomedicine presents a powerful tool for TME modulation due to its spatiotemporal control and long-lasting effects.

Purpose of the Study:

• To review recent advancements in nanomedicine for re-engineering the tumor microenvironment.
• To highlight nanomedicine formulations targeting cellular components within the TME.
• To discuss the goal of re-engineering the TME to a quiescent phenotype.

Main Methods:

• Review of current literature on nanomedicine applications in TME modulation.
• Focus on nanomedicine formulations designed for targeted interaction with TME cellular components.
• Analysis of strategies for controlling TME characteristics using nanomedicine.

Main Results:

• Nanomedicine enables precise control over drug action within the TME.
• Targeted nanomedicines can effectively modify TME characteristics.
• Successful TME re-engineering aims to induce a quiescent state, not destruction.

Conclusions:

• Nanomedicine holds significant potential for developing novel cancer therapies by re-engineering the TME.
• Targeted nanomedicine approaches offer a promising avenue for enhancing therapeutic outcomes.
• Future innovations in TME-re-engineering nanomedicines are anticipated to advance cancer treatment.